A SERM increasing the expression of the osteoblastogenesis and mineralization-related proteins and improving quality of bone tissue in an experimental model of osteoporosis
Abstract Raloxifene is an antiresorptive drug, selective estrogen receptor modulator (SERM) used in the treatment of osteoporosis. Objective To evaluate proteins related to bone repair at the peri-implant bone in a rat model of osteoporosis treated with raloxifene. Material and Methods 72 rats wer...
Main Authors: | Fernanda Costa Yogui, Gustavo Antonio Correa Momesso, Leonardo Perez Faverani, Tarik Ocon Braga Polo, Gabriel Ramalho-Ferreira, Jaqueline Suemi Hassumi, Ana Cláudia Rossi, Alexandre Rodrigues Freire, Felippe Bevilacqua Prado, Roberta Okamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
University of São Paulo
2018-05-01
|
Series: | Journal of Applied Oral Science |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-77572018000100447&lng=en&tlng=en |
Similar Items
-
The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01) -
The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01) -
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01) -
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01)